Compare ARK Genomic Revolution ETF (ARKG) vs Dicks Sporting Goods Inc (DKS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Dicks Sporting Goods Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Dicks Sporting Goods Inc trades at $217.98 (market cap $19.51B). The key difference: Dicks Sporting Goods Inc pays a 2.29% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Dicks Sporting Goods Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | DKS | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $239.17 |
52-Week Low | $23.09 | $187.78 |
Market Cap | — | $19.51B |
Enterprise Value | — | $26.30B |
Dividend Yield | — | 2.29% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
DKS trades at $217.98, up 0.3% on the day, with a bearish technical signal but strong fundamentals including a 6% comps growth in Q1 2026 and three consecutive quarterly earnings beats. Recent developments include the launch of the ScoreCard+ loyalty program and a partnership with Lids to expand fan merchandise in over 100 stores by late summer 2026. The stock shows robust profitability with a 20.9% ROE and a 4.71% net income margin, supported by $1.17B net income in 2025.
The outlook is positive with a consensus price target of $261, representing 19.7% upside, and no sell ratings among 64 analysts. Key risks include ongoing shareholder litigation over fiduciary duties and competitive pressures in sporting goods retail. The stock presents a growth opportunity driven by strategic expansions and consistent earnings performance, though investors should monitor legal developments and market share sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Dicks Sporting Goods Inc
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →
